Foresite Capital Management III’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$35.2M Hold
2021
Q2
$34.3M Hold
2021
Q1
$49.3M Buy
2020
Q4
$10.5M Buy
2020
Q3
$1.76M Buy
2019
Q1
Sell
2018
Q4
$1.96M Sell
2018
Q3
$4.54M Hold
2018
Q2
$6.24M Hold
2018
Q1
$5.47M Buy
2017
Q4
$5.25M Sell
2017
Q3
$6.79M Buy
2017
Q2
Sell
2017
Q1
$4.17M Sell
2016
Q4
$4.23M Buy